9/27/2023 | 30021500 | BROLUCIZUMAB SOLUTION FOR INJECTION 120 MG/ML-756974(BATCH-SJTH7)(IL/BIO-000136-RC/BIO-000133 VALID 12/7/2026) | XXXXXXXXXX | 9600 | PCS | 1405545.41 | SWITZERLAND | BASLE |
9/27/2023 | 30021500 | SECUKINUMAB LYVI 150 MG GLW (X1) IN (SCAPHO) (BATCH NO SKCT6 )(FORM 10 LICENCE NO FF-401-41 VALID 31/10/2024) | XXXXXXXXXX | 12980 | PCS | 1095949.4 | SWITZERLAND | BASLE |
9/26/2023 | 30021500 | RTH258 6MG/0.05ML 0.23ML (VIAL) BATCH 2049178 (TL/CT/23/000198 DATE 18/09/2023) (CLINICAL TRIAL) (FOC) | XXXXXXXXXX | 150 | PCS | 21364.75 | SWITZERLAND | BASLE |
9/26/2023 | 30021500 | SECUKINUMAB LYVI 150 MG GLW (X1) IN (SCAPHO) (BATCH NO SJYD5 )(FORM 10 LICENCE NO FF-401-41 VALID 31/10/2024) | XXXXXXXXXX | 7990 | PCS | 674625.24 | SWITZERLAND | BASLE |
9/26/2023 | 30021500 | ACCENTRIX LIVI 0.5MG/0.05ML 1X1 IN(FN)-760044BATCH-SJPM6-RANIBIZUMAB 10MG/SOLUTION (FORM 10-IL/BIO-000096-FF401 VALID UP | XXXXXXXXXX | 16988 | PCS | 2277959.37 | SWITZERLAND | BASLE |
9/22/2023 | 30021500 | BROLUCIZUMAB SOLUTION FOR INJECTION 120 MG/ML-756974 (BATCH-SJTH7)(IL/BIO-000136-RC/BIO-000133) | XXXXXXXXXX | 6790 | PCS | 994130.56 | SWITZERLAND | BASLE |
9/21/2023 | 30021500 | SECUKINUMAB LYVI 150 MG GLW (X1) IN-735419(BATCH-SKCA2) FORM10- FF-401-41 VALID 31/10/2024 | XXXXXXXXXX | 7990 | PCS | 673822.6 | SWITZERLAND | BASLE |
9/20/2023 | 30021500 | KADCYLA VIAL 15ML 100MG 1(TRASTUZUMAB EMTANSINE) (PAC)(FOR SUPPLY UNDER PATIENT ASSISTANCE PROGRAMMES)(PAC)(MONOCLONAL A | XXXXXXXXXX | 685 | NOS | 220189.15 | SWITZERLAND | BASLE |
9/18/2023 | 30021500 | SECUKINUMAB LYVI 150 MG GLW (X1) IN (SCAPHO) (BATCH NO SJYW2 )(FORM 10 LICENCE NO FF-401-41 VALID 31/10/2024) | XXXXXXXXXX | 7990 | PCS | 673822.6 | SWITZERLAND | BASLE |
9/6/2023 | 30021500 | PHESGO SOLUTION FOR INJECTION 600MG/600MG 10ML VIAL 1 (PAC)(PERTUZUMAB TRASTUZUMAB INJECTION) | XXXXXXXXXX | 943 | NOS | 364851.73 | SWITZERLAND | BASLE |